Dolby Laboratories (DLB) CMO reports new equity awards and vesting
Rhea-AI Filing Summary
Dolby Laboratories, Inc. executive Todd Pendleton, SVP and Chief Marketing Officer, reported new equity awards and related share movements. On 12/15/2025 he received 18,848 restricted stock units, 9,424 performance-based restricted stock units, and options for 41,500 shares of Class A common stock at $66.62, all subject to multi-year vesting conditions.
On the same dates, 5,233 performance-based units from a prior award vested after a three-year performance period, while Dolby withheld 6,056 shares at $67.54 and 1,959 shares at $66.62 to cover taxes tied to vesting. After these transactions he beneficially owned 53,356 Class A shares, and shares held included 41,480 shares underlying restricted stock units that remain subject to forfeiture until they vest.
Positive
- None.
Negative
- None.
FAQ
What insider transactions did Dolby Laboratories (DLB) disclose for its CMO?
Dolby Laboratories' SVP and Chief Marketing Officer, Todd Pendleton, reported multiple equity transactions. On 12/15/2025 he acquired 18,848 restricted stock units (RSUs) and 5,233 shares of Class A common stock from vesting performance-based RSUs, and received options for 41,500 shares. On 12/15/2025 and 12/16/2025, Dolby also withheld shares to cover taxes related to RSU and performance-based RSU vesting.
How many restricted stock units and stock options did the DLB executive receive, and how do they vest?
The executive was granted 18,848 RSUs and options for 41,500 shares of Class A common stock at an exercise price of $66.62. Under the RSU grant, one quarter of the units vest on each anniversary of 12/15/2025. For the option grant, one quarter vests on the first anniversary of 12/15/2025, and the remaining shares vest in equal monthly installments over the following 36 months.
What are the terms of the new performance-based restricted stock unit award at Dolby Laboratories (DLB)?
The new performance-based restricted stock unit award covers 9,424 units, each representing a right to receive one share of Class A common stock upon vesting. Vesting depends on performance measured over a three-year period from 12/15/2025 to 12/12/2028 and a service-based condition. The reporting person may earn from 0% to 200% of the 9,424-unit target based on annualized total shareholder return versus the S&P Mid Cap 400 Index, with vesting occurring after three years and certification by the Compensation Committee.
What was the outcome of the earlier performance-based share award reported by DLB?
The prior performance-based award had a target of 8,094 units measured over a three-year period from 12/15/2022 to 12/10/2025. The Compensation Committee certified achievement at 64.65% of the target, resulting in 5,233 performance-based restricted stock units vesting and 2,861 units being cancelled. The service-based vesting condition was satisfied upon certification of the performance results.
How many Dolby Laboratories (DLB) shares does the CMO beneficially own after these transactions?
Following the reported transactions on 12/15/2025 and 12/16/2025, the executive beneficially owned 53,356 shares of Dolby Laboratories Class A common stock. Shares held after these transactions include 41,480 shares underlying restricted stock units that are subject to forfeiture until they vest.
Were any Dolby Laboratories shares sold or withheld to cover taxes in this Form 4?
Yes. On 12/15/2025, 6,056 shares were disposed of at $67.54, and on 12/16/2025, 1,959 shares were disposed of at $66.62. According to the disclosure, these shares were withheld by Dolby in a transaction exempt from Section 16(b) to cover withholding taxes related to the vesting of restricted stock units and performance-based restricted stock units, rather than being issued to the reporting person.